Skip to main content
Have a personal or library account? Click to login
A Large-Scale Screening Responding Sporadic Epidemic of COVID-19 in China by an Integrated Health-Care System Cover

A Large-Scale Screening Responding Sporadic Epidemic of COVID-19 in China by an Integrated Health-Care System

Open Access
|Mar 2022

References

  1. Zhang Y, Wang Q. Study on Urban and Rural Medical and Health Resources Allocation Balance in China (in Chinese). Medicine and Society. 2016; 29(1): 79. DOI: 10.13723/j.yxysh.2016.01.003
  2. Zhou X, Liu X, Guo Y. Ideas of Reform of Public Health Expenditure under the Framework of Public Financing. Chinese Health Service Management. 2006; 10: 5857. DOI: 10.3969/j.issn.1004-4663.2006.10.003
  3. Meng Q, Mills A, Wang L. et al. What can we learn from China’s health system reform? Bmj. 2019; 365: l2349. DOI: 10.1136/bmj.l2349
  4. Wang Y, Chen X. Study on the Equity of Health Resource Allocation in Guangdong Province. Medicine and Society. 2016; 29(1): 136. DOI: 10.13723/j.yxysh.2016.01.005
  5. World Bank Group, World Health Organization, P.R.C. Ministry of Finance, et al. Deepening Health Reform in China: The World Bank Group; 2016.
  6. World Health Organization. Integrated care for older people (ICOPE) implementation framework: guidance for systems and services. World Health Organization. 2019; 41.
  7. Longest BB, Young GJ. Coordination and communication. In: Shortell S, Kaluzny A (eds.), Health Care Management. Albany: Organization design and behavior. 2000; 21043. NY: Delmar.
  8. Soni N, Pai P, Kumar G. et al. A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases. Future Virology. 2020; 15. DOI: 10.2217/fvl-2020-0141
  9. World Health Organization. Coronavirus disease (COVID-19) pandemic: WHO Coronavirus (COVID-19) Dashboard 2021 [cited 2022 January 12]. Available from: https://covid19.who.int/.
  10. Tu H, Tu S, Gao S. et al. Current epidemiological and clinical features of COVID-19; a global perspective from China. J Infect. 2020; 81(1): 19. DOI: 10.1016/j.jinf.2020.04.011
  11. Hu Z, Ci C. Screening and management of asymptomatic infection of corona virus disease 2019 (COVID-19). Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2020; 54: E025. DOI: 10.3760/cma.j.cn112150-20200229-00220
  12. He J, Guo Y, Mao R. et al. Proportion of asymptomatic coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Journal of Medical Virology. 2020; 93. DOI: 10.1002/jmv.26326
  13. Hu Z, Song C, Xu C. et al. Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened among Close Contacts in Nanjing, China. Science China: Life Sciences. 2020; 63(5): 6. DOI: 10.1101/2020.02.20.20025619
  14. Sastry S, Pryor R, Raybould J. et al. Universal Screening for the SARS-CoV-2 virus on Hospital Admission in an area with low COVID-19 Prevalence. Infection Control & Hospital Epidemiology. 2020; 41: 19. DOI: 10.1017/ice.2020.358
  15. Wilmes P, Zimmer J, Schulz J. et al. Mass Screening for SARS-CoV-2 Uncovers Significant Transmission Risk from Asymptomatic Carriers. SSRN Electronic Journal; 2020. DOI: 10.2139/ssrn.3738086
  16. Cao S, Gan Y, Wang C. et al. Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China. Nature Communications. 2020; 11(1): 5917. DOI: 10.1038/s41467-020-19802-w
  17. Viktoria Stein K, Barbazza ES, Tello J. et al. Towards people-centred health services delivery: a Framework for Action for the World Health Organisation (WHO) European Region. Int J Integr Care. 2013; 13: e058. DOI: 10.5334/ijic.1514
  18. Girum T, Lentiro K, Geremew M. et al. Global strategies and effectiveness for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic review. Trop Med Health. 2020; 48(1): 91. DOI: 10.1186/s41182-020-00285-w
  19. Vardoulakis S, Sheel M, Lal A. et al. COVID-19 environmental transmission and preventive public health measures. Australian and New Zealand Journal of Public Health. 2020; 44(5): 3335. DOI: 10.1111/1753-6405.13033
  20. Woloshin S, Patel N, Kesselheim AS. False Negative Tests for SARS-CoV-2 Infection – Challenges and Implications. N Engl J Med. 2020; 383(6): e38. DOI: 10.1056/NEJMp2015897
  21. The Harbin News. The largest nucleic acid testing laboratory in Heilongjiang Province has been put into use: with a daily detection capacity of more than 6000 copies (in Chinese) [cited 2021 March 10]; updated May 5 2020. Available from: https://baijiahao.baidu.com/s?id=1665781305597783034&wfr=spider&for=pc.
  22. Lighting News: The Official Account of Shandong Radio and Television Station. Jinan’s nucleic acid detection capacity exceeded 10000 copies (in Chinese) [cited 2021 March 10]; updated February 20 2020. Available from: https://baijiahao.baidu.com/s?id=1659048764672494655&wfr=spider&for=pc.
  23. The Ningxia News. 36 medical and health institutions are capable of nucleic acid detection with an average of 16000 people can be detected per day (in Chinese); updated September 11 2020. Available from: https://www.nxnews.net/yc/jrww/202009/t20200911_6853723.html.
  24. Xi’an Release: the Official Account of Xi’an Newspaper Media Group (Xi’an Daily). Shaanxi strongest medical laboratory center: 50000 nucleic acid tests per day (in Chinese) [cited 2021 March 10]; updated September 10 2020. Available from: https://baijiahao.baidu.com/s?id=1677442006805869062&wfr=spider&for=pc.
  25. Ben-Ami R, Klochendler A, Seidel M. et al. Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection. Clinical Microbiology and Infection. 2020; 26(9): 124853. DOI: 10.1016/j.cmi.2020.06.009
  26. Skoll D, Miller JC, Saxon LA. COVID-19 testing and infection surveillance: Is a combined digital contact-tracing and mass-testing solution feasible in the United States? Cardiovascular Digital Health Journal. 2020; 1(3): 14959. DOI: 10.1016/j.cvdhj.2020.09.004
  27. Arons MM, Hatfield KM, Reddy SC. et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med. 2020; 382(22): 208190. DOI: 10.1056/NEJMoa2008457
  28. Su Y, Anderson D, Young B. et al. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2. mBio. 2020; 11. DOI: 10.1128/mBio.01610-20
  29. Eyawo O, Viens AM, Ugoji UC. Lockdowns and low- and middle-income countries: building a feasible, effective, and ethical COVID-19 response strategy. Globalization and Health. 2021; 17(1): 13. DOI: 10.1186/s12992-021-00662-y
DOI: https://doi.org/10.5334/ijic.5941 | Journal eISSN: 1568-4156
Language: English
Submitted on: Mar 10, 2021
Accepted on: Mar 15, 2022
Published on: Mar 23, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Xuru He, Xizhuo Sun, Fangfang Gong, Wenhai Li, Jinchun Lin, Hanqun Lin, Guangyu Hu, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.